首页> 外文期刊>The Internet Journal of Infectious Diseases >Evaluation Results of 21th Iranian External Quality Assessment Schemes (EQAS) of Microbiology laboratories in 2007
【24h】

Evaluation Results of 21th Iranian External Quality Assessment Schemes (EQAS) of Microbiology laboratories in 2007

机译:2007年第21个伊朗微生物实验室外部质量评估计划(EQAS)的评估结果

获取原文
           

摘要

The aim of this study was to determine ability of Iranian microbiology laboratories for identification and susceptibility testing of two unknown microorganisms. In Feb 2007 21st run of proficiency testing of Iranian microbiology laboratories carried out by Iranian reference health laboratories. In this survey two unknown microorganisms including Salmonella paratyphi B and Staphylococcus aureus were submitted to 1305 microbiology laboratories. Of 1305 laboratories, 1122(.86%) laboratories participated in our survey and 183 (14%) laboratories did not participated in our program. Of 1122 laboratories, 523(46.6%) laboratories identified S.paratyphi B correctly. The results of susceptibility testing of S.paratyphi B were relatively satisfied for nalidixic acid, ciprofloxacin and trimethoprim-sulfamethoxazole. However the results of susceptibility testing for tetracycline and ampicillin were unsatisfied and only 578 (52.5%) and 558 (49.7%) Of laboratories reported correct answer for tetracycline and ampicillin respectively. Regarding to identification Staphylococus aureus of 1122 laboratories 767 (68.4%) identified this organism correctly It is concluded that the majority of microbiology laboratories were able for identification of S.parathyphi B and S.aureus. Nearly 50% of laboratories produced incorrect susceptibility testing answer according to S.paratyphi B for tetracycline and ampicillin. Introduction Blind retesting of previously analyzed specimens can be used an assessment in number of different areas of the microbiology laboratory, such as appropriate setup based on the source of the unknown organism ,correct identification of unknown organism, appropriate titters of infectious disease of serologies testing and reporting of antimicrobial susceptibility testing results and many more. (1,2,3,4,5).This processes called external quality assessment scheme (EQAS), competency assessment or proficiency testing. There are many benefits for participation in the EQAS for laboratories.(i) participating laboratories are able to assess whether their results are comparable with those of other laboratories. (ii) EQAS can provide a valuable educational stimulates to laboratory staff. (iii) It provides credibility to the participating laboratory by providing evidence that the participating laboratory has a responsible attitude towards quality issues (evidence of participation is required by some acceding agencies); (iv) EQA provides an insight into national performance levels; and (v) EQAS improves national performance levels. (1,5) The Iranian national external quality assessment scheme for microbiology laboratories were introduced in 1994 for evaluation of performance and competency testing of microbiology laboratories in both governmental and private sectors. The scheme covers a wide range of clinical microbiology activities including identification and susceptibility testing. We annually perform three run of EQAS programs .In microbiology laboratories various steps have been taken to upgrade the EQAS programs. In recent years, the scheme has been actively promoted throughout country resulting increased participation. In spite of regular performance of EQAS by reference laboratory of Iran, many microbiology laboratories are not able for identification and performance of correct susceptibility testing of some microorganisms. Our recent studies showed that nearly one third of microbiology laboratories in Tehran were not able to identify three unknown microorganisms such as Acinetobacter baumannii, Enerococcus faecalis and Enterobacter agglomerans.(6) The aim of this study was to determine ability of Iranian microbiology laboratories for identification and susceptibility testing of three unknown microorganisms. Methods In Feb 2007 21st run of proficiency testing of Iranian microbiology laboratories carried out by research center and reference laboratories of Iran. In this survey two unknown microorganisms including Salmonella Paratyphi B and
机译:这项研究的目的是确定伊朗微生物学实验室对两种未知微生物进行鉴定和药敏试验的能力。 2007年2月,由伊朗参考卫生实验室对伊朗微生物实验室进行了第21次水平测试。在这项调查中,包括副伤寒沙门氏菌B和金黄色葡萄球菌在内的两种未知微生物已提交给1305个微生物实验室。在1305个实验室中,有1122个(.86%)实验室参加了我们的调查,有183个实验室(14%)没有参加我们的计划。在1122个实验室中,有523(46.6%)个实验室正确地鉴定了副伤寒沙门氏菌。对于萘啶酸,环丙沙星和甲氧苄啶-磺胺甲基异恶唑,副伤寒沙门氏菌B的药敏试验结果相对满意。然而,对四环素和氨苄青霉素的药敏试验结果仍不令人满意,只有578(52.5%)和558(49.7%)个实验室分别报告了四环素和氨苄青霉素的正确答案。在鉴定方面,有1122个实验室的金黄色葡萄球菌767个(占68.4%)正确地鉴定了该生物体。结论是,大多数微生物实验室能够鉴定副甲状腺链球菌B和金黄色葡萄球菌。根据副伤寒沙门氏菌B对四环素和氨苄青霉素的试验,近50%的实验室给出了不正确的药敏试验答案。简介先前分析过的标本的盲测可用于评估微生物实验室的许多不同领域,例如根据未知生物的来源进行适当设置,正确识别未知生物,适当的血清学检测传染病滴度和报告抗菌药物敏感性测试结果等等。 (1,2,3,4,5)。此过程称为外部质量评估计划(EQAS),能力评估或能力测试。参与实验室的EQAS有很多好处。(i)参与实验室能够评估其结果是否与其他实验室的结果可比。 (ii)EQAS可以为实验室人员提供宝贵的教育刺激。 (iii)通过提供证据证明参与实验室对质量问题负有负责任的态度(参与的机构要求参加的证据)来提供参与实验室的信誉; (iv)EQA可以洞悉国家绩效水平; (v)EQAS提高了国家绩效水平。 (1,5)1994年引入了伊朗国家微生物实验室外部质量评估计划,以评估政府和私营部门中微生物实验室的性能和能力测试。该计划涵盖了广泛的临床微生物学活动,包括鉴定和药敏试验。我们每年执行三轮EQAS计划。在微生物实验室,已采取了各种步骤来升级EQAS计划。近年来,该计划已在全国范围内积极推广,从而增加了参与度。尽管伊朗参考实验室会定期执行EQAS,但许多微生物实验室仍无法识别和执行某些微生物的正确药敏试验。我们最近的研究表明,德黑兰近三分之一的微生物实验室无法鉴定三种未知微生物,如鲍氏不动杆菌,粪肠球菌和团聚肠杆菌。(6)这项研究的目的是确定伊朗微生物实验室的鉴定能力以及三种未知微生物的敏感性测试。方法2007年2月,由伊朗研究中心和参考实验室对伊朗微生物实验室进行了第21次能力验证。在这项调查中,两种未知微生物包括副伤寒沙门氏菌B和

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号